Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons

scientific article published on 01 August 1992

Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.12.8.879
P953full work available at URLhttps://www.ahajournals.org/doi/pdf/10.1161/01.ATV.12.8.879
P698PubMed publication ID1637785

P2093author name stringP. K. Siegl
C. T. Dunwiddie
J. T. Davidson
G. P. Vlasuk
L. W. Schaffer
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectthrombosisQ261327
Cardiology and cardiovascular medicineQ96320350
direct Xa inhibitorQ906280
P304page(s)879-885
P577publication date1992-08-01
P1433published inArteriosclerosis and thrombosis : a journal of vascular biologyQ27709770
P1476titleSelective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons
P478volume12

Reverse relations

cites work (P2860)
Q35672783A Novel Direct Factor Xa Inhibitory Peptide with Anti-Platelet Aggregation Activity from Agkistrodon acutus Venom Hydrolysates
Q77153138Antithrombotic effect of YM-75466 is separated from its effect on bleeding time and coagulation time
Q41972518Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time
Q74014924Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis
Q74551385Blood flow and antithrombotic drug effects
Q28190575Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy
Q40463597Novel Antithrombotic Drugs in Development
Q40725160Novel antithrombotic therapy.
Q34027530Novel inhibitors of factor X for use in cardiovascular diseases
Q53772864Preincubation of Dacron grafts with recombinant tissue factor pathway inhibitor decreases their thrombogenicity in vivo.
Q43911200The discovery of YM-60828: a potent, selective and orally-bioavailable factor Xa inhibitor
Q57310720YM-60828, a novel factor Xa inhibitor: Separation of its antithrombotic effects from its prolongation of bleeding time

Search more.